Lycopene improves on basic hematological and immunological parameters in diabetes mellitus.

Area of Science:

• Hematology
• Immunology
• Nutritional Science

Background:

• Diabetes mellitus significantly alters hematological and immunological profiles.
• Anemia is a reported complication in diabetic chemotherapy, necessitating safety research.
• Limited data exists on Lycopene's impact on these parameters in diabetes.

Purpose of the Study:

• To investigate the effects of Lycopene on hematological parameters in diabetic rats.
• To assess Lycopene's potential as a supportive agent in managing diabetes-related complications.
• To establish hematological markers for Lycopene's safety and efficacy.

Main Methods:

• Administration of Lycopene to diabetic rat models.
• Monitoring of key hematological parameters, including red blood cell counts, white blood cell differentials, and platelet counts.
• Analysis of albumin and globulin levels to assess general physiological status.

Main Results:

• Lycopene exhibited dose-independent anti-anemic effects in diabetic rats.
• Improvements in immune status were observed, with decreased neutrophil counts and neutrophil-lymphocyte ratio.
• Platelet counts were reduced, while albumin and globulin levels remained stable, indicating a balanced physiological effect.

Conclusions:

• Lycopene positively influences hematological parameters in diabetic rats.
• The compound may exert protective effects by balancing physiological variables.
• Further research into Lycopene's role in diabetes management is warranted.